Bharat Parenter.

{
  "main_header": {
    "sid": 1002949,
    "name": "Bharat Parenter.",
    "stock_name": "Bharat Parenter.",
    "full_name": "Bharat Parenterals Ltd",
    "name_url": "stocks-analysis/bharat-parenter",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,200.00",
    "chg": -1.55,
    "chgp": "-0.13%",
    "dir": -1,
    "prev_price": "1,201.55",
    "mcapval": "810.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541096,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE365Y01019",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": 290,
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bharat-parenter-1002949-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bharat Parenterals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-parenterals-ltd-is-rated-strong-sell-3778831",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BharatParentera_mojoScore_3778831.png",
        "date": "2026-01-02 10:10:03",
        "description": "Bharat Parenterals Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bharat Parenter. Sees Revision in Market Assessment Amid Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-parenter-downgraded-to-strong-sell-amid-weak-fundamentals-and-risky-valuation-3765624",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BharatParenter_mojoScore_3765624.png",
        "date": "2025-12-22 10:10:18",
        "description": "Bharat Parenter., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting ongoing challenges in its financial and operational metrics. The recent changes in evaluation metrics highlight concerns across quality, valuation, financial trends, and technical outlook, underscoring the company’s current position within a competitive and volatile market environment."
      },
      {
        "title": "Bharat Parenterals Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-sees-mixed-technical-signals-amid-price-momentum-shift-3761994",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BharatParentera_technicaldot_3761994.png",
        "date": "2025-12-18 08:14:27",
        "description": "Bharat Parenterals has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market forces within the Pharmaceuticals & Biotechnology sector. Recent price movements and technical indicators suggest a transition from a predominantly bearish stance to a more mildly bearish outlook, underscoring the evolving market assessment of this micro-cap stock."
      },
      {
        "title": "Why is Bharat Parenter. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bharat-parenter-fallingrising-3749671",
        "imagepath": "",
        "date": "2025-12-06 01:41:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Bharat Parenterals has experienced a notable slide in its stock price over multiple time horizons. In the past week, the share price fell by 4.43%, contrasting sharply with the Sensex’s marginal gain of 0.01%. Over the last month, the stock declined by 10.02%, while the Sensex advanced by 2.70%. Year-to-date figures reveal a more pronounced divergence, with Bharat Parenterals down 25.06% against the Sensex’s 9.69% rise. The one-year performance further highlights the stock’s struggles, registering a 35.41% loss compared to the Sensex’s 4.83% gain. Despite these setbacks, the stock has delivered strong long-term returns, with three- and five-year gains of 179.33% and 220.28% respectively, outperforming the Sensex’s 36.41% and 90.14% ..."
      },
      {
        "title": "Is Bharat Parenter. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bharat-parenter-technically-bullish-or-bearish-3747964",
        "imagepath": "",
        "date": "2025-12-05 08:51:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Technical Trend Overview</strong></p>\n<p>As of 04 Dec 2025, the technical trend for Bharat Parenter. has shifted decisively from mildly bearish to bearish. This change reflects increasing downward pressure on the stock, signalling a potential continuation of weakness in the near term. The daily moving averages reinforce this view, showing a bearish alignment that typically suggests sellers are in control.</p>\n<p>Further technical indicators provide a nuanced picture. The Moving Average Convergence Divergence (MACD) on a weekly basis is bearish, while the monthly MACD remains mildly bearish. This divergence suggests that while short-term momentum is clearly negative, longer-term momentum is only moderately weak, indicating some underlying resilience but insufficient to reverse the downtrend.<..."
      },
      {
        "title": "Bharat Parenterals Technical Momentum Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-faces-bearish-momentum-amid-technical-downgrade-3747793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BharatParentera_technicaldot_3747793.png",
        "date": "2025-12-05 08:10:24",
        "description": "Bharat Parenterals, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent evaluation adjustments highlight a transition in technical indicators, signalling a more cautious outlook amid broader market fluctuations."
      },
      {
        "title": "Bharat Parenterals Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-forms-death-cross-signalling-potential-bearish-trend-3747056",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BharatParentera_dealthcross_3747056.png",
        "date": "2025-12-04 18:03:27",
        "description": "Bharat Parenterals, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests potential long-term weakness in the stock’s price trajectory."
      },
      {
        "title": "Bharat Parenter. Sees Revision in Market Assessment Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-parenter-downgraded-to-strong-sell-amid-weak-fundamentals-and-risky-valuation-3738097",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BharatParenter_mojoScore_3738097.png",
        "date": "2025-12-01 10:09:16",
        "description": "Bharat Parenter., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The recent shift in analytical perspective highlights concerns across multiple parameters including quality, valuation, financial trends, and technical outlook, underscoring the company’s current position within a competitive and volatile market environment."
      },
      {
        "title": "Bharat Parenterals Faces Financial Trend Adjustments Amid Mixed Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-financial-trend-declines-from-flat-to-negative-amid-sales-challenges-3697473",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BharatParentera_fintrenddot_3697473.png",
        "date": "2025-11-13 11:04:24",
        "description": "Bharat Parenterals has experienced a flat financial performance for the quarter ending September 2025, despite a 22.69% increase in net sales for the first nine months. The company maintains a strong balance sheet with a commendable debt-equity ratio, though recent quarterly sales have declined significantly."
      }
    ],
    "total": 383,
    "sid": "1002949",
    "stock_news_url": "https://www.marketsmojo.com/news/bharat-parenterals-1002949"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Jan-2026",
      "details": "Newspaper Advertisement under regulation 30 of SEBI LODR(Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Jan-2026",
      "details": "Compliance certificate as per regulation 74(5) of SEBI (DP) Regulations 2018.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Jan-2026",
      "details": "Newspaper Advertisement under Regulation 30 of SEBI LODR (Listing Obligations and Disclosures Requirements) Regulations 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bharat Parenterals Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bharat Parenterals Ltd is Rated Strong Sell

2026-01-02 10:10:03

Bharat Parenterals Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 29 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bharat Parenter. Sees Revision in Market Assessment Amid Challenging Fundamentals

2025-12-22 10:10:18

Bharat Parenter., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting ongoing challenges in its financial and operational metrics. The recent changes in evaluation metrics highlight concerns across quality, valuation, financial trends, and technical outlook, underscoring the company’s current position within a competitive and volatile market environment.

Read full news article

Bharat Parenterals Technical Momentum Shifts Amid Mixed Market Signals

2025-12-18 08:14:27

Bharat Parenterals has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market forces within the Pharmaceuticals & Biotechnology sector. Recent price movements and technical indicators suggest a transition from a predominantly bearish stance to a more mildly bearish outlook, underscoring the evolving market assessment of this micro-cap stock.

Read full news article

Why is Bharat Parenter. falling/rising?

2025-12-06 01:41:55

Recent Price Movement and Market Comparison

Bharat Parenterals has experienced a notable slide in its stock price over multiple time horizons. In the past week, the share price fell by 4.43%, contrasting sharply with the Sensex’s marginal gain of 0.01%. Over the last month, the stock declined by 10.02%, while the Sensex advanced by 2.70%. Year-to-date figures reveal a more pronounced divergence, with Bharat Parenterals down 25.06% against the Sensex’s 9.69% rise. The one-year performance further highlights the stock’s struggles, registering a 35.41% loss compared to the Sensex’s 4.83% gain. Despite these setbacks, the stock has delivered strong long-term returns, with three- and five-year gains of 179.33% and 220.28% respectively, outperforming the Sensex’s 36.41% and 90.14% ...

Read full news article

Is Bharat Parenter. technically bullish or bearish?

2025-12-05 08:51:25

Technical Trend Overview

As of 04 Dec 2025, the technical trend for Bharat Parenter. has shifted decisively from mildly bearish to bearish. This change reflects increasing downward pressure on the stock, signalling a potential continuation of weakness in the near term. The daily moving averages reinforce this view, showing a bearish alignment that typically suggests sellers are in control.

Further technical indicators provide a nuanced picture. The Moving Average Convergence Divergence (MACD) on a weekly basis is bearish, while the monthly MACD remains mildly bearish. This divergence suggests that while short-term momentum is clearly negative, longer-term momentum is only moderately weak, indicating some underlying resilience but insufficient to reverse the downtrend.<...

Read full news article

Bharat Parenterals Technical Momentum Shifts Amid Market Volatility

2025-12-05 08:10:24

Bharat Parenterals, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent evaluation adjustments highlight a transition in technical indicators, signalling a more cautious outlook amid broader market fluctuations.

Read full news article

Bharat Parenterals Forms Death Cross Signalling Potential Bearish Trend

2025-12-04 18:03:27

Bharat Parenterals, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests potential long-term weakness in the stock’s price trajectory.

Read full news article

Bharat Parenter. Sees Revision in Market Assessment Amidst Challenging Fundamentals

2025-12-01 10:09:16

Bharat Parenter., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The recent shift in analytical perspective highlights concerns across multiple parameters including quality, valuation, financial trends, and technical outlook, underscoring the company’s current position within a competitive and volatile market environment.

Read full news article

Bharat Parenterals Faces Financial Trend Adjustments Amid Mixed Performance Indicators

2025-11-13 11:04:24

Bharat Parenterals has experienced a flat financial performance for the quarter ending September 2025, despite a 22.69% increase in net sales for the first nine months. The company maintains a strong balance sheet with a commendable debt-equity ratio, though recent quarterly sales have declined significantly.

Read full news article

View All News